Literature DB >> 21736503

Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.

Niklas Schaefer, Katja Rasch, Markus Moehlenbruch, Horst Urbach, Moritz Stuplich, Elias Blasius, Bjoern Scheffler, Ulrich Herrlinger, Martin Glas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21736503     DOI： 10.3109/0284186X.2011.586001

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  6 in total

1.  Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance.

Authors:  Inna Smalley; Vincent Law; Clayton Wyatt; Brittany Evernden; Bin Fang; John M Koomen; Eric A Welsh; Robert J B Macaulay; Peter A Forsyth; Keiran S M Smalley
Journal:  Clin Cancer Res       Date:  2020-01-10       Impact factor: 12.531

Review 2.  Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.

Authors:  Keiran S M Smalley; Inna V Fedorenko; Rajappa S Kenchappa; Solmaz Sahebjam; Peter A Forsyth
Journal:  Int J Cancer       Date:  2016-04-30       Impact factor: 7.396

Review 3.  Neuro-ophthalmologic complications of neoplastic leptomeningeal disease.

Authors:  Gabriella Szatmáry
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

Review 4.  Melanoma central nervous system metastases: current approaches, challenges, and opportunities.

Authors:  Justine V Cohen; Hussain Tawbi; Kim A Margolin; Ravi Amravadi; Marcus Bosenberg; Priscilla K Brastianos; Veronica L Chiang; John de Groot; Isabella C Glitza; Meenhard Herlyn; Sheri L Holmen; Lucia B Jilaveanu; Andrew Lassman; Stergios Moschos; Michael A Postow; Reena Thomas; John A Tsiouris; Patrick Wen; Richard M White; Timothy Turnham; Michael A Davies; Harriet M Kluger
Journal:  Pigment Cell Melanoma Res       Date:  2016-10-22       Impact factor: 4.693

Review 5.  Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.

Authors:  Katharine Hall Thomas; Robert A Ramirez
Journal:  Ochsner J       Date:  2017

6.  Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report.

Authors:  Dae Won Kim; Edelyn Barcena; Urvi N Mehta; Michelle L Rohlfs; Ashok J Kumar; Marta Penas-Prado; Kevin B Kim
Journal:  BMC Cancer       Date:  2015-05-13       Impact factor: 4.430
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.